[1] Li SS,Mody CH.Cryptococcus[J].Proc Am Thorac Soc,2010,7(3):186-196.
[2] Kwon-Chung KJ,Fraser JA,Doering TL,et al.Cryptococcus neoformans and Cryptococcus gattii,the etiologic agents of cryptococcosis[J].Cold Spring Harb Perspect Med,2014,4(7):a019760.
[3] Levitz SM.The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis[J].Rev Infect Dis,1991,13(6):1163-1169.
[4] Lui G,Lee N,Ip M,Choi KW,et al.Cryptococcosis in apparently immunocompetent patients[J].QJM,2006,99(3):143-151.
[5] Chen J,Varma,Diaz MR,Litvintseva AP,et al.Cryptococcus neoformans strains and infection in apparently immunocompetent patients,China[J].Emerg Infect Dis,2008,14(5):755-762.
[6] Carniato A,Scotton PG,Miotti AM,et al.Cryptococcus neoformans meningoencephalitis among apparently immunocompetent patients:description of two cases[J].Infez Med,2009,17(1):41-45.
[7] Mansour MK,Levitz SM.Interactions of fungi with phagocytes[J].Curr Opin Microbiol,2002,5(4):359-365.
[8] Vecchiarelli A,Pietrella D,Dottorini M,et al.Encapsulation of Cryptococcus neoformans regulates fungicidal activity and the antigen presentation process in human alveolar macrophages[J].Clin Exp Immunol,1994,98(2):217-223.
[9] Vecchiarelli A,Dottorini M,Pietrella D,et al.Role of human alveolar macrophages as antigen-presenting cells in Cryptococcus neoformans infection[J].Am J Respir Cell Mol Biol,1994,11(2):130-137.
[10] Kechichian TB,Shea J,Del Poeta M.Depletion of alveolar macrophages decreases the dissemination of a glucosylceramide-deficient mutant of Cryptococcus neoformans in immunodeficient mice[J].Infect Immun,2007,75(10):4792-4798.
[11] Griffin FM Jr.Roles of macrophage Fc and C3b receptors in phagocytosis of immunologically coated Cryptococcus neoformans[J].Proc Natl Acad Sci U S A,1981,78(6):3853-3857.
[12] Kozel TR,Follette JL.Opsonization of encapsulated Cryptococcus neoformans by specific anticapsular antibody[J].Infect Immun,1981,31(3):978-984.
[13] Mitchell TG,Perfect JR.Cryptococcosis in the era of AIDS——100 years after the discovery of Cryptococcus neoformans[J].Clin Microbiol Rev 1995,8(4):515-548.
[14] Bulmer GS,Tacker JR.Phagocytosis of Cryptococcus neoformans by alveolar macrophages[J].Infect Immun,1975,11(1):73-79.
[15] Dong ZM,Murphy JW.Cryptococcal polysaccharides bind to CD18 on human neutrophils[J].Infect Immun,1997,65(2):557-563.
[16] Lipovsky MM,Gekker G,Anderson WR,et al.Phagocytosis of nonopsonized Cryptococcus neoformans by swine microglia involves CD14 receptors[J].Clin Immunol Immunopathol,1997,84(2):208-211.
[17] Shoham S,Huang C,Chen JM,et al.Toll-like receptor 4 mediates intracellular signaling without TNF-alpha release in response to Cryptococcus neoformans polysaccharide capsule[J].J Immunol,2001,166(7):4620-4626.
[18] Gilbert AS,Wheeler RT,May RC.Fungal pathogens:survival and replication within macrophages[J].Cold Spring Harb Perspect Med,2014,5(7):a019661.
[19] Davis CH.Myxopapillary ependymoma with intracranial metastases by Higgins G,Smith C,Summers D,Statham P,Erridge S.Br J Neurosurg 2005,19(4):356-8[J].Br J Neurosurg,2006,20(2):114.
[20] Levitz SM,Tabuni A.Binding of Cryptococcus neoformans by human cultured macrophages.Requirements for multiple complement receptors and actin[J].J Clin Invest,1991,87(2):528-535.
[21] Zaragoza O,Taborda CP,Casadevall A.The efficacy of complement-mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirect C3-mediated interactions[J].Eur J Immunol,2003,33(7):1957-1967.
[22] Levitz SM,Harrison TS,Tabuni A,et al.Chloroquine induces human mononuclear phagocytes to inhibit and kill Cryptococcus neoformans by a mechanism independent of iron deprivation[J].J Clin Invest,1997,100(6):1640-1646.
[23] Luo Y,Cook E,Fries BC,et al.Phagocytic efficacy of macrophage-like cells as a function of cell cycle and Fcgamma receptors (FcgammaR) and complement receptor (CR)3 expression[J].Clin Exp Immunol,2006,145(2):380-387.
[24] Monari C,Casadevall A,Pietrella D,et al.Neutrophils from patients with advanced human immunodeficiency virus infection have impaired complement receptor function and preserved Fcgamma receptor function[J].J Infect Dis,1999,180(5):1542-1549.
[25] Tucker SC,Casadevall A.Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm[J].Proc Natl Acad Sci U S A,2002,99(5):3165-3170.
[26] Kelly RM,Chen J,Yauch LE,et al.Opsonic requirements for dendritic cell-mediated responses to Cryptococcus neoformans[J].Infect Immun,2005,73(1):592-598.
[27] Syme RM,Spurrell JC,Amankwah EK,et al.Primary dendritic cells phagocytose Cryptococcus neoformans via mannose receptors and Fcgamma receptor Ⅱ for presentation to T lymphocytes[J].Infect Immun,2002,70(11):5972-5981.
[28] Wozniak KL,Vyas JM,Levitz SM.In vivo role of dendritic cells in a murine model of pulmonary cryptococcosis[J].Infect Immun,2006,74(7):3817-3824.
[29] Crowley M,Inaba K,Steinman RM.Dendritic cells are the principal cells in mouse spleen bearing immunogenic fragments of foreign proteins[J].J Exp Med,1990,172(1):383-386.
[30] Xu J,Eastman AJ,Flaczyk A,et al.Disruption of early tumor necrosis factor alpha signaling prevents classical activation of dendritic cells in lung-associated lymph nodes and development of protective immunity against cryptococcal infection[J].MBio,2016,7(4):e00510-16.
[31] Bauman SK,Nichols KL,Murphy JW.Dendritic cells in the induction of protective and nonprotective anticryptococcal cell-mediated immune responses[J].J Immunol,2000,165(1):158-167.
[32] Osterholzer JJ,Milam JE,Chen GH,et al.Role of dendritic cells and alveolar macrophages in regulating early host defense against pulmonary infection with Cryptococcus neoformans[J].Infect Immun,2009,77(9):3749-3758.
[33] Levitz SM,Specht CA.The molecular basis for the immunogenicity of Cryptococcus neoformans mannoproteins[J].FEMS Yeast Res,2006,6(4):513-524.
[34] Mansour MK,Latz E,Levitz SM.Cryptococcus neoformans glycoantigens are captured by multiple lectin receptors and presented by dendritic cells[J].J Immunol,2006,176(5):3053-3061.
[35] Gadebusch HH,Johnson AG.Natural host resistance to infection with Cryptococcus neoformans.V.The influence of cationic tissue proteins upon phagocytosis and on circulating antibody synthesis[J].J Infect Dis,1966,116(5):566-572.
[36] Pfrommer GS,Dickens SM,Wilson MA,et al.Accelerated decay of C3b to iC3b when C3b is bound to the Cryptococcus neoformans capsule[J].Infect Immun,1993,61(10):4360-4366.
[37] Chaturvedi V,Wong B,Newman SL.Oxidative killing of Cryptococcus neoformans by human neutrophils.Evidence that fungal mannitol protects by scavenging reactive oxygen intermediates[J].J Immunol,1996,156(10):3836-3840.
[38] Mambula SS,Simons ER,Hastey R,et al.Human neutrophil-mediated nonoxidative antifungal activity against Cryptococcus neoformans[J].Infect Immun,2000,68(11):6257-6264.
[39] Miller MF,Mitchell TG.Killing of Cryptococcus neoformans strains by human neutrophils and monocytes[J].Infect Immun,1991,59(1):24-28.
[40] Perfect JR,Lang SD,Durack DT.Chronic cryptococcal meningitis:a new experimental model in rabbits[J].Am J Pathol,1980,101(1):177-194.
[41] Mednick AJ,Feldmesser M,Rivera J,et al.Neutropenia alters lung cytokine production in mice and reduces their susceptibility to pulmonary cryptococcosis[J].Eur J Immunol,2003,33(6):1744-1753.
[42] Feldmesser M,Kress Y,Novikoff P,et al.Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection[J].Infect Immun,2000,68(7):4225-4237.
[43] Lehrer RI,Ganz T.Antimicrobial polypeptides of human neutrophils[J].Blood,1990,76(11):2169-2181.
[44] Eisenhauer PB,Lehrer RI.Mouse neutrophils lack defensins[J].Infect Immun 1992,60(8):3446-3447.
[45] Feldmesser M,Tucker S,Casadevall A.Intracellular parasitism of macrophages by Cryptococcus neoformans[J].Trends Microbiol,2001,9(6):273-278.
[46] Alvarez M,Casadevall A.Cell-to-cell spread and massive vacuole formation after Cryptococcus neoformans infection of murine macrophages[J].BMC Immunol,2007,8(1):16.
[47] Del Poeta M.Role of phagocytosis in the virulence of Cryptococcus neoformans[J].Eukaryot Cell,2004,3(5):1067-1075.
[48] Ma H,Croudace JE,Lammas DA,May RC.Direct cell-to-cell spread of a pathogenic yeast[J].BMC Immunol,2007,8(1):15.
[49] Mantovani A,Biswas SK,Galdiero MR,et al.Macrophage plasticity and polarization in tissue repair and remodelling[J].J Pathol,2013,229(2):176-185.
[50] Levitz SM,Nong SH,Seetoo KF,et al.Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages[J].Infect Immun,1999,67(2):885-890.
[51] Shoham S,Levitz SM.The immune response to fungal infections[J].Br J Haematol,2005,129(5):569-582.
[52] Southwick FS,Purich DL.Intracellular pathogenesis of listeriosis[J].N Engl J Med,1996,334(12):770-776.
[53] Zaragoza O,Chrisman CJ,Castelli MV,et al.Capsule enlargement in Cryptococcus neoformans confers resistance to oxidative stress suggesting a mechanism for intracellular survival[J].Cell Microbiol,2008,10(10):2043-2057.
[54] Feldmesser M,Mednick A,Casadevall A.Antibody-mediated protection in murine Cryptococcus neoformans infection is associated with pleotrophic effects on cytokine and leukocyte responses[J].Infect Immun,2002,70(3):1571-1580.
[55] Alvarez M,Casadevall A.Phagosome extrusion and host-cell survival after Cryptococcus neoformans phagocytosis by macrophages[J].Curr Biol 2006,16(21):2161-2165.
[56] Ma H,Croudace JE,Lammas DA,et al.Expulsion of live pathogenic yeast by macrophages[J].Curr Biol,2006,16(21):2156-2160.
[57] Alvarez M,Saylor C,Casadevall A.Antibody action after phagocytosis promotes Cryptococcus neoformans and Cryptococcus gattii macrophage exocytosis with biofilm-like microcolony formation[J].Cell Microbiol,2008,10(8):1622-1633.
[58] Williamson PR,Jarvis JN,Panackal AA,et al.Cryptococcal meningitis:epidemiology,immunology,diagnosis and therapy[J].Nat Rev Neurol,2017,13(1):13-24.
[59] Walker JA,McKenzie AN.Development and function of group 2 innate lymphoid cells[J].Curr Opin Immunol,2013,25(2):148-155.